News that the FDA is investigating metformin products to determine if potentially carcinogenic agents are present was one of the week’s top stories in endocrinology.
Another top story was about a study suggesting bioactive metabolites found in coffee may be associated with a beneficial effect on bone mineral density in adults.
FDA assessing potentially harmful substance in metformin products
Potential carcinogenic agents may be present in metformin based on reports from non-U.S. countries, which has prompted an investigation from the FDA, according to an agency statement. Read more.
Metabolites found in coffee may improve bone health
Several bioactive metabolites found in coffee may be associated with a beneficial effect on bone mineral density among healthy adults who report regular coffee consumption, according to findings published in The Journal of Clinical Endocrinology & Metabolism. Read more.
Exercise and cardiometabolic health: ‘Never too late to start exercising’
Exercise provides important and varied benefits for individuals with cardiometabolic disorders regardless of experience level, and certain exercise types may yield better outcomes for those with certain conditions, according to a speaker at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease. Read more.
Ketogenic diet ‘viable patient choice’ for type 2 diabetes
Adherence to a ketogenic eating plan, with proper medical support, could yield diabetes remission and sustained cardiometabolic improvements in a person with type 2 diabetes, according to a speaker at the World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease. Read more.
Elevated BMI, waist size increase congestive HF, mortality risks in type 2 diabetes
Among adults with type 2 diabetes, the risks for congestive heart failure and all-cause mortality rise with increases in BMI and waist circumference, but there may be a need to reevaluate what constitutes obesity using these metrics, according to findings published in the Journal of Diabetes and its Complications. Read more.